Favorable outcome in a renal transplant recipient with donor-derived infection due to multidrug-resistant Pseudomonas aeruginosa

Transplant Infectious Disease

Volumn 14, Issue 3, 2012, Pages 292-295

  Simkins, J ^a   Muggia, V ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Donor derived infection; Multidrug resistant; Pseudomonas aeruginosa; Vascular dehiscence

Indexed keywords

AMIKACIN; CEFAZOLIN; CREATININE; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BLOOD CULTURE; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DONOR DERIVED INFECTION; FEVER; FOLLOW UP; GRAFT INFECTION; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; LUNG INFILTRATE; MALE; MULTIDRUG RESISTANCE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; SURGICAL WOUND; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMYXIN B; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84862214271     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00674.x     Document Type: Article

References (14)

1. Ison MG, Hager J, Blumberg E, et al. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009; 9 (8): 1929-1935.
2. Grossi PA, Fishman JA. Donor-derived infections in solid organ transplant recipients. Am J Transplant 2009; 9 (SUPPL 4): S19-S26.
3. Battaglia M, Ditonno P, Selvaggio O, et al. Kidney transplants from infected donors: our experience. Transplant Proc 2004; 36 (3): 491-492.
4. Cerutti E, Stratta C, Romagnoli R, et al. Bacterial- and fungal-positive cultures in organ donors: clinical impact in liver transplantation. Liver Transpl 2006; 12 (8): 1253-1259.
5. Orlando G, Di Cocco P, Gravante G, D'Angelo M, Famulari A, Pisani F. Fatal hemorrhage in two renal graft recipients with multi-drug resistant Pseudomonas aeruginosa infection. Transpl Infect Dis 2009; 11 (5): 442-447.
6. Kumar D, Cattral MS, Robicsek A, Gaudreau C, Humar A. Outbreak of Pseudomonas aeruginosa by multiple organ transplantation from a common donor. Transplantation 2003; 75 (7): 1053-1055.
7. Nelson PW, Delmonico FL, Tolkoff-Rubin NE, et al. Unsuspected donor Pseudomonas infection causing arterial disruption after renal transplantation. Transplantation 1984; 37 (3): 313-314.
8. Komori Y, Nonogaki T, Nikai T. Hemorrhagic activity and muscle damaging effect of Pseudomonas aeruginosa metalloproteinase (elastase). Toxicon 2001; 39 (9): 1327-1332.
9. Geary KJ, Tomkiewicz ZM, Harrison HN, et al. Differential effects of a gram-negative and a gram-positive infection on autogenous and prosthetic grafts. J Vasc Surg 1990; 11 (2): 339-345.
10. Edwards NM, Claridge JA, Shell DH4th, Handorf CR, Croce MA, Fabian TC. The effect of bacterial contamination on neointimal hyperplasia in vascular grafts. Am Surg 2006; 72 (12): 1168-1174.
11. Fischer SA, Avery RK. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2009; 9 (SUPPL 4): S7-18.
12. Organ Procurement and Transplantation Network. Minimum procurement standards for an Organ Procurement Organization to reduce risk of donor derived infection. Available at
13. Bowden RA, Ljungman P, Snydman DR. Transplant Infections. In: Ison MG, ed. Donor-Derived Infections: Incidence, Prevention and Management (3rd edn). Philadelphia: Wolter Kluwer/Lippincot Williams & Wilkins, 2010: 77-89.
14. Snydman DR. Posttransplant microbiological surveillance. Clin Infect Dis 2001; 33 (SUPPL 1): S22-S25.